1. Market Research
  2. > Healthcare
  3. > Medical Supply Market Trends
  4. > Hemostats Market by Product Type, and Geography - Global Forecast to 2020

The global hemostats market size is projected to reach USD 2.76 billion by 2020, at a CAGR of 6.2% during from 2015 to 2020. Increasing number of surgery procedures and increasing number of insurance providers to bear the high cost of this medical devices like hemostats products, are the major factors influencing the growth of this market.

The administration and monitoring of hemostats during surgical procedures is a complex task for clinicians, as it depends upon the blood flow from the particular area of surgery. The usage of hemostats have no adverse effects and is an important procedure to prevent blood loss in patients, especially among the aging population. The market for hemostats is rapidly increasing with technological advancements and increasing number of surgeries. Also, hospitals and healthcare facilities are gradually increasing, supported by government which in turn is driving the growth of the hemostats market.

Hemostats is one of the sub-markets of wound closure devices. Over the years, these products have been used during surgeries to stop bleeding within a short span of time. These products are biodegradable, absorbable, and cost-effective. They have a tenure of maximum 2 years with no adverse effects.

Based on product type, this market is segmented into thrombin based hemostats, combination hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, and collagen based hemostats, thrombin based hemostats, combination hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, and collagen based hemostats.

Based on geography, the global hemostats market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The growth in the Americas hemostats market is attributed to the increase in number of surgical procedures. However, the hemostats market in Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. Increasing healthcare infrastructure along with rise in number of surgeries are propelling the growth of this market.

The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis. Some of the companies profiled in this report are Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.).


Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis, market share analysis of top players, supply chain analysis, and company profiles. All of these together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities for the global Hemostats market.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.

The report provides insights on the following pointers:
- Product Analysis and Development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the global hemostats market are provided.
- Market Development: Comprehensive information about lucrative emerging markets is provided. The report also analyzes the markets for hemostats across various regions, exploit new distribution channels, new clientele base, and different pricing policies.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the global hemostats market is provided. Detailed description regarding the related and unrelated diversification pertaining to this market is also provided.
- Competitive Assessment: An in-depth assessment of market shares and company share analysis of the key players forecasted till 2020 is provided.

Table Of Contents

Hemostats Market by Product Type, and Geography - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET SEGMENTATION and COVERAGE 18
1.3 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 INTEGRATED ECOSYSTEM OF THE HEMOSTATS MARKET 20
2.1.1 TOP-DOWN APPROACH 21
2.1.2 BOTTOM-UP APPROACH 22
2.1.3 MACRO INDICATOR- BASED APPROACH 22
2.1.4 UNIT PRICE ANALYSIS 23
2.1.5 PRODUCT MATRIX 24
2.1.6 PORTER'S FIVE FORCES MODEL 25
2.1.7 LIFE EXPECTANCY RATE 25
2.2 ASSUMPTIONS 26
3 EXECUTIVE SUMMARY 27
4 MARKET OVERVIEW 28
4.1 INTRODUCTION 28
4.2 MARKET DRIVERS AND INHIBITORS 28
4.3 KEY MARKET DYNAMICS 28
5 HEMOSTATS MARKET, BY PRODUCT TYPE 31
5.1 INTRODUCTION 32
5.1.1 THROMBIN BASED HEMOSTATS 33
5.1.2 OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS 35
5.1.3 COMBINATION HEMOSTATS 36
5.1.4 GELATIN BASED HEMOSTATS 38
5.1.5 COLLAGEN BASED HEMOSTATS 39
6 HEMOSTATS MARKET, BY GEOGRAPHY 41
6.1 INTRODUCTION 42
6.2 AMERICAS 43
6.2.1 U.S. 45
6.2.2 CANADA 46
6.2.3 MEXICO 48
6.2.4 BRAZIL 49
6.2.5 ARGENTINA 51
6.2.6 CHILE 52
6.2.7 COLOMBIA 54
6.2.8 PARAGUAY 55
6.2.9 URUGUAY 57
6.3 EUROPE 58
6.3.1 GERMANY 61
6.3.2 FRANCE 62
6.3.3 U.K. 64
6.3.4 ITALY 65
6.3.5 SPAIN 67
6.3.6 RUSSIA 68
6.3.7 SWITZERLAND 70
6.3.8 THE NETHERLANDS 71
6.3.9 BELGIUM 73
6.3.10 DENMARK 74
6.3.11 TURKEY 76
6.4 ASIA-PACIFIC 78
6.4.1 JAPAN 80
6.4.2 CHINA 82
6.4.3 INDIA 83
6.4.4 AUSTRALIA 85
6.4.5 REPUBLIC OF KOREA 86
6.4.6 THAILAND 88
6.4.7 SINGAPORE 89
6.4.8 VIETNAM 91
6.4.9 TAIWAN 92
6.4.10 MALAYSIA 94
6.4.11 INDONESIA 95
6.4.12 NEW ZEALAND 97
6.5 MIDDLE EAST and AFRICA (MEA) 99
6.5.1 EGYPT 101
6.5.2 SAUDI ARABIA 103
6.5.3 UAE 104
6.5.4 ISRAEL 106
6.5.5 OMAN 107
6.5.6 KUWAIT 109
6.5.7 ZIMBABWE 110
6.5.8 KENYA 112
6.5.9 JORDAN 113
6.5.10 ALGERIA 115
6.5.11 MOROCCO 116
6.5.12 LIBYA 118
6.5.13 TUNISIA 119
6.5.14 SUDAN 121
6.5.15 SOUTH AFRICA 122
6.5.16 MAURITIUS 124
7 COMPETITIVE LANDSCAPE 126
7.1 COMPANY SHARE ANALYSIS 126
7.1.1 U.S 126
7.1.2 CANADA 126
7.1.3 BRAZIL 127
7.1.4 GERMANY 128
7.1.5 FRANCE 128
7.1.6 U.K. 129
7.1.7 CHINA 130
7.1.8 INDIA 130
7.1.9 JAPAN 131
7.2 PRODUCT LAUNCHES 132
7.3 MERGERS AND ACQUISITIONS 133
7.4 COLLABORATIONS, JOINT AGREEMENTS and EXPANSIONS, PARTNERSHIPS 134
7.5 APPROVALS, ALLIANCES, RELOCATIONS and LICENSING, AND NEW BRAND STRATEGY 134
8 HEMOSTATS MARKET, BY COMPANY 135
8.1 JOHNSON and JOHNSON SERVICES, INC. 135
8.1.1 BUSINESS OVERVIEW 135
8.1.2 KEY FINANCIALS 135
8.1.3 PRODUCT AND SERVICE OFFERINGS 136
8.1.4 RELATED DEVELOPMENTS 137
8.1.5 MNM VIEW 137
8.2 C. R. BARD, INC. 138
8.2.1 BUSINESS OVERVIEW 138
8.2.2 KEY FINANCIALS 138
8.2.3 PRODUCT AND SERVICE OFFERINGS 139
8.2.4 RELATED DEVELOPMENTS 139
8.2.5 MNM VIEW 139
8.3 BAXTER 140
8.3.1 OVERVIEW 140
8.3.2 KEY FINANCIALS 140
8.3.3 PRODUCT AND SERVICE OFFERINGS 141
8.3.4 RELATED DEVELOPMENTS 141
8.3.5 MNM VIEW 142

8.4 B. BRAUN MELSUNGEN AG 143
8.4.1 BUSINESS OVERVIEW 143
8.4.2 KEY FINANCIALS 143
8.4.3 PRODUCTS AND SERVICE OFFERINGS 144
8.4.4 RECENT DEVELOPMENTS 145
8.4.5 MNM VIEW 145
8.5 PFIZER INC. 146
8.5.1 BUSINESS OVERVIEW 146
8.5.2 KEY FINANCIALS 146
8.5.3 PRODUCTS AND SERVICE OFFERINGS 147
8.5.4 RECENT DEVELOPMENTS 147
8.5.5 MNM VIEW 147
8.6 VASCULAR SOLUTIONS, INC. 148
8.6.1 BUSINESS OVERVIEW 148
8.6.2 KEY FINANCIALS 148
8.6.3 PRODUCTS AND SERVICE OFFERINGS 149
8.6.4 RECENT DEVELOPMENTS 150
8.6.5 MNM VIEW 150
8.7 GELITA MEDICAL GMBH 151
8.7.1 BUSINESS OVERVIEW 151
8.7.2 PRODUCTS AND SERVICE OFFERINGS 151
8.7.3 RECENT DEVELOPMENTS 151
8.7.4 MNM VIEW 151
8.8 EQUIMEDICAL 152
8.8.1 BUSINESS OVERVIEW 152
8.8.2 PRODUCTS AND SERVICE OFFERINGS 152
8.8.3 MNM VIEW 152
8.9 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 153
8.9.1 BUSINESS OVERVIEW 153
8.9.2 KEY FINANCIALS 153
8.9.3 PRODUCT AND SERVICE OFFERINGS 154
8.9.4 MNM VIEW 154
8.10 Z-MEDICA, LLC 155
8.10.1 BUSINESS OVERVIEW 155
8.10.2 PRODUCT AND SERVICE OFFERINGS 155
8.10.3 RELATED DEVELOPMENTS 155
8.10.4 MNM VIEW 155
8.11 MARINE POLYMER TECHNOLOGIES, INC. 156
8.11.1 BUSINESS OVERVIEW 156
8.11.2 PRODUCT AND SERVICE OFFERINGS 156
8.11.3 MNM VIEW 156
9 APPENDIX 157
9.1 CUSTOMIZATION OPTIONS 157
9.1.1 REGULATORY FRAMEWORK 157
9.1.2 IMPACT ANALYSIS 157
9.2 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 158
9.3 RELATED REPORTS 159


LIST OF TABLES

TABLE 1 UNIT PRICE ANALYSIS 23
TABLE 2 HEMOSTATS MARKET: DRIVERS AND INHIBITORS 28
TABLE 3 HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 28
TABLE 4 HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN) 29
TABLE 5 COLLAGEN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN) 29
TABLE 6 THROMBIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN) 29
TABLE 7 GELATIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN) 29
TABLE 8 COMBINATION HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN) 30
TABLE 9 OXIDIZED REGENERATION COLLAGEN BASED HEMOSTATS MARKET,
BY GEOGRAPHY, 2013-2020 (USD MN) 30
TABLE 10 HEMOSTATS MARKET, BY PRODUCT TYPE, 2013 - 2020 (USD MN) 32
TABLE 11 HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 33
TABLE 12 THROMBIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN) 34
TABLE 13 THROMBIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013 - 2020 (UNITS) 34
TABLE 14 OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET,
BY GEOGRAPHY, 2013-2020 (USD MN) 35
TABLE 15 OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013 - 2020 (UNITS) 36
TABLE 16 COMBINATION HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN) 37
TABLE 17 COMBINATION HEMOSTATS MARKET, BY GEOGRAPHY, 2013 - 2020 (UNITS) 37
TABLE 18 GELATIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN) 38
TABLE 19 GELATIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013 - 2020 (UNITS) 39
TABLE 20 COLLAGEN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013-2020 (USD MN) 40
TABLE 21 COLLAGEN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2013 - 2020 (UNITS) 40
TABLE 22 HEMOSTATS MARKET, BY REGION, 2013-2020 (USD MN) 42
TABLE 23 AMERICAS HEMOSTATS MARKET, BY COUNTRY, 2013-2020 (USD MN) 44
TABLE 24 AMERICAS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 44
TABLE 25 U.S. HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 45
TABLE 26 U.S. HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 45
TABLE 27 U.S. HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 46
TABLE 28 CANADA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 47
TABLE 29 CANADA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 47
TABLE 30 CANADA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 47
TABLE 31 MEXICO HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 48
TABLE 32 MEXICO HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 48
TABLE 33 MEXICO HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 49
TABLE 34 BRAZIL HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 49
TABLE 35 BRAZIL HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 50
TABLE 36 BRAZIL HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 50
TABLE 37 ARGENTINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 51
TABLE 38 ARGENTINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 51
TABLE 39 ARGENTINA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 52
TABLE 40 CHILE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 52
TABLE 41 CHILE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 53
TABLE 42 CHILE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 53
TABLE 43 COLOMBIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 54
TABLE 44 COLOMBIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 54
TABLE 45 COLOMBIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 55
TABLE 46 PARAGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 55
TABLE 47 PARAGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 56
TABLE 48 PARAGUAY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 56
TABLE 49 URUGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 57
TABLE 50 URUGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 57
TABLE 51 URUGUAY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 58
TABLE 52 EUROPE HEMOSTATS MARKET, BY COUNTRY, 2013-2020 (USD MN) 59
TABLE 53 EUROPE HEMOSTATS MARKET VALUE, BY PRODUCT TYPE, 2013-2020 (USD MN) 60
TABLE 54 GERMANY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 61
TABLE 55 GERMANY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 61
TABLE 56 GERMANY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 62
TABLE 57 FRANCE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 62
TABLE 58 FRANCE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 63
TABLE 59 FRANCE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 63
TABLE 60 U.K. HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 64
TABLE 61 U.K. HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 64
TABLE 62 U.K. HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 65
TABLE 63 ITALY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 65
TABLE 64 ITALY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 66
TABLE 65 ITALY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 66
TABLE 66 SPAIN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 67
TABLE 67 SPAIN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 67
TABLE 68 SPAIN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 68
TABLE 69 RUSSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 68
TABLE 70 RUSSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 69
TABLE 71 RUSSIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 69
TABLE 72 SWITZERLAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 70
TABLE 73 SWITZERLAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 70
TABLE 74 SWITZERLAND HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 71
TABLE 75 THE NETHERLANDS HEMOSTATS MARKET, BY PRODUCT TYPE,
2013-2020 (USD MN) 71
TABLE 76 THE NETHERLANDS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 72
TABLE 77 THE NETHERLANDS HEMOSTATS MARKET AVERAGE SELLING PRICE,
BY PRODUCT TYPE, 2013-2020 (USD) 72
TABLE 78 BELGIUM HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 73
TABLE 79 BELGIUM HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 73
TABLE 80 BELGIUM HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 74
TABLE 81 DENMARK HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 74
TABLE 82 DENMARK HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 75
TABLE 83 DENMARK HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 75
TABLE 84 TURKEY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 76
TABLE 85 TURKEY HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 76
TABLE 86 TURKEY HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 77
TABLE 87 ASIA-PACIFIC HEOMSTATS MARKET, BY COUNTRY, 2013-2020 (USD MN) 79
TABLE 88 ASIA-PACIFIC HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 80
TABLE 89 JAPAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 80
TABLE 90 JAPAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 81
TABLE 91 JAPAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 81
TABLE 92 CHINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 82
TABLE 93 CHINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 82
TABLE 94 CHINA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 83
TABLE 95 INDIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 83
TABLE 96 INDIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 84
TABLE 97 INDIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 84
TABLE 98 AUSTRALIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 85
TABLE 99 AUSTRALIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 85
TABLE 100 AUSTRALIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 86
TABLE 101 REPUBLIC OF KOREA HEMOSTATS MARKET, BY PRODUCT TYPE,
2013-2020 (USD MN) 87
TABLE 102 REPUBLIC OF KOREA HEMOSTATS MARKET, BY PRODUCT TYPE,
2013-2020 (UNITS) 87
TABLE 103 REPUBLIC OF KOREA HEMOSTATS MARKET AVERAGE SELLING PRICE,
BY PRODUCT TYPE, 2013-2020 (USD) 87
TABLE 104 THAILAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 88
TABLE 105 THAILAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 88
TABLE 106 THAILAND HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 89
TABLE 107 SINGAPORE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 90
TABLE 108 SINGAPORE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 90
TABLE 109 SINGAPORE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 90
TABLE 110 VIETNAM HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 91
TABLE 111 VIETNAM HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 91
TABLE 112 VIETNAM HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 92
TABLE 113 TAIWAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 92
TABLE 114 TAIWAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 93
TABLE 115 TAIWAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 93
TABLE 116 MALAYSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 94
TABLE 117 MALAYSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 94
TABLE 118 MALAYSIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 95
TABLE 119 INDONESIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 95
TABLE 120 INDONESIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 96
TABLE 121 INDONESIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 96
TABLE 122 NEW ZEALAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 97
TABLE 123 NEW ZEALAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 97
TABLE 124 NEW ZEALAND HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 98
TABLE 125 MIDDLE EAST and AFRICA HEMOSTATS MARKET, BY COUNTRY,
2013-2020 (USD MN) 100
TABLE 126 MIDDLE EAST and AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE,
2013-2020 (USD MN) 101
TABLE 127 EGYPT HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 101
TABLE 128 EGYPT HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 102
TABLE 129 EGYPT HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 102
TABLE 130 SAUDI ARABIA HEMOSTATS, BY PRODUCT TYPE, 2013-2020 (USD MN) 103
TABLE 131 SAUDI ARABIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 103
TABLE 132 SAUDI ARABIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 104
TABLE 133 UAE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 105
TABLE 134 UAE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 105
TABLE 135 UAE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 105
TABLE 136 ISRAEL HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 106
TABLE 137 ISRAEL HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 106
TABLE 138 ISRAEL HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 107
TABLE 139 OMAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 107
TABLE 140 OMAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 108
TABLE 141 OMAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 108
TABLE 142 KUWAIT HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 109
TABLE 143 KUWAIT HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 109
TABLE 144 KUWAIT HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 110
TABLE 145 ZIMBABWE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 110
TABLE 146 ZIMBABWE HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 111
TABLE 147 ZIMBABWE HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 111
TABLE 148 KENYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 112
TABLE 149 KENYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 112
TABLE 150 KENYA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 113
TABLE 151 JORDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 113
TABLE 152 JORDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 114
TABLE 153 JORDAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 114
TABLE 154 ALGERIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 115
TABLE 155 ALGERIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 115
TABLE 156 ALGERIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 116
TABLE 157 MOROCCO HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 116
TABLE 158 MOROCCO HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 117
TABLE 159 MOROCCO HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 117
TABLE 160 LIBYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 118
TABLE 161 LIBYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 118
TABLE 162 LIBYA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 119
TABLE 163 TUNISIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 119
TABLE 164 TUNISIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 120
TABLE 165 TUNISIA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 120
TABLE 166 SUDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 121
TABLE 167 SUDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 121
TABLE 168 SUDAN HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE,
2013-2020 (USD) 122
TABLE 169 SOUTH AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 122
TABLE 170 SOUTH AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 123
TABLE 171 SOUTH AFRICA HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 123
TABLE 172 MAURITIUS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 124
TABLE 173 MAURITIUS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (UNITS) 124
TABLE 174 MAURITIUS HEMOSTATS MARKET AVERAGE SELLING PRICE, BY PRODUCT TYPE, 2013-2020 (USD) 125
TABLE 175 HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 126
TABLE 176 CANADA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 127
TABLE 177 BRAZIL HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 127
TABLE 178 GERMANY HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 128
TABLE 179 FRANCE HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 129
TABLE 180 U.K. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 129
TABLE 181 CHINA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 130
TABLE 182 INDIA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 131
TABLE 183 JAPAN HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 131
TABLE 184 PRODUCT LAUNCHES 132
TABLE 185 MERGERS AND ACQUISITIONS 133
TABLE 186 COLLABORATIONS, JOINT AGREEMENTS and EXPANSIONS, PARTNERSHIPS 134
TABLE 187 APPROVALS, ALLIANCES, RELOCATION and LICENSING, AND NEW BRAND STRATEGY 134
TABLE 188 JOHNSON and JOHNSON SERVICES, INC.: REVENUE, BY BUSINESS SEGMENT,
2011-2014 (USD MN) 135
TABLE 189 JOHNSON and JOHNSON SERVICES, INC.: REVENUE, BY GEOGRAPHIC SEGMENT, 2011-2014 (USD MN) 136
TABLE 190 C. R. BARD, INC.: REVENUE, BY BUSINESS SEGMENTS, 2010-2014 (USD MN) 138
TABLE 191 BAXTER: REVENUE, BY BUSINESS SEGMENTS, 2010-2014 (USD MN) 140
TABLE 192 BAXTER: REVENUE, BY GEOGRAPHIC SEGMENT, 2010-2014 (USD MN) 141
TABLE 193 B. BRAUN MELSUNGEN AG: REVENUE, BY BUSINESSS SEGMENT,
2010-2014 (USD MN) 143
TABLE 194 B. BRAUN MELSUNGEN AG: REVENUE, BY GEOGRAPHIC SEGMENT,
2010-2014 (USD MN) 144
TABLE 195 PFIZER INC.: REVENUE MIX, 2010-2014 (USD MN) 146
TABLE 196 PFIZER INC.: REVENUE, BY GEOGRAPHIC SEGMENT 2010-2014 (USD MN) 146
TABLE 197 VASCULAR SOLUTIONS, INC.: REVENUE, BY SEGMENT, 2010-2014 (USD MN) 148
TABLE 198 VASCULAR SOLUTIONS, INC.: REVENUE, BY GEOGRAPHIC SEGMENT,
2010-2014 (USD MN) 149
TABLE 199 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE, BY BUSINESS SEGMENT, 2011 - 2014 (USD MN) 153


LIST OF FIGURES

FIGURE 1 HEMOSTATS MARKET SEGMENTATION and COVERAGE 18
FIGURE 2 HEMOSTATS MARKET: INTEGRATED ECOSYSTEM 20
FIGURE 3 TOP-DOWN APPROACH 21
FIGURE 4 BOTTOM-UP APPROACH 22
FIGURE 5 MACRO INDICATOR-BASED APPROACH 23
FIGURE 6 LIFE EXPECTANCY RATE 25
FIGURE 7 HEMOSTATS MARKET SNAPSHOT 2014 27
FIGURE 8 HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 32
FIGURE 9 THROMBIN BASED HEMOSTATS MARKET, BY GEOGRAPHY,
2015 and 2020 (USD MN) 33
FIGURE 10 OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET,
BY GEOGRAPHY, 2015 and 2020 (USD MN) 35
FIGURE 11 COMBINATION HEMOSTATS MARKET, BY GEOGRAPHY, 2015 and 2020 (USD MN) 36
FIGURE 12 GELATIN BASED HEMOSTATS MARKET, BY GEOGRAPHY, 2015 and 2020 (USD MN) 38
FIGURE 13 COLLAGEN BASED HEMOSTATS MARKET, BY GEOGRAPHY,
2015 and 2020 (USD MN) 39
FIGURE 14 HEMOSTATS MARKET, BY REGION, 2015 and 2020 (USD MN) 42
FIGURE 15 AMERICAS HEMOSTATS MARKET, BY COUNTRY, 2014 and 2020 (USD MN) 43
FIGURE 16 AMERICAS HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 44
FIGURE 17 U.S. HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 45
FIGURE 18 CANADA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 46
FIGURE 19 MEXICO HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 48
FIGURE 20 BRAZIL HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 49
FIGURE 21 ARGENTINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 51
FIGURE 22 CHILE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 52
FIGURE 23 COLOMBIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 54
FIGURE 24 PARAGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 55
FIGURE 25 URUGUAY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 57
FIGURE 26 EUROPE HEMOSTATS MARKET, BY COUNTRY, 2014 and 2020 (USD MN) 59
FIGURE 27 EUROPE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 60
FIGURE 28 GERMANY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 61
FIGURE 29 FRANCE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 62
FIGURE 30 U.K. HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 64
FIGURE 31 ITALY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 65
FIGURE 32 SPAIN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 67
FIGURE 33 RUSSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 68
FIGURE 34 SWITZERLAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 70
FIGURE 35 THE NETHERLANDS HEMOSTATS MARKET, BY PRODUCT TYPE,
2015 and 2020 (USD MN) 71
FIGURE 36 BELGIUM HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 73
FIGURE 37 DENMARK HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 74
FIGURE 38 TURKEY HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 76
FIGURE 39 ASIA-PACIFIC HEMOSTATS MARKET, BY COUNTRY, 2014 and 2020 (USD MN) 78
FIGURE 40 ASIA-PACIFIC HEMOSTATS MARKET VALUE, BY PRODUCT TYPE,
2015 and 2020 (USD MN) 79
FIGURE 41 JAPAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 80
FIGURE 42 CHINA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 82
FIGURE 43 INDIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 83
FIGURE 44 AUSTRALIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 85
FIGURE 45 REPUBLIC OF KOREA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 86
FIGURE 46 THAILAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 88
FIGURE 47 SINGAPORE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 89
FIGURE 48 VIETNAM HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 91
FIGURE 49 TAIWAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 92
FIGURE 50 MALAYSIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 94
FIGURE 51 INDONESIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 95
FIGURE 52 NEW ZEALAND HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 97
FIGURE 53 MIDDLE EAST and AFRICA HEMOSTATS MARKET, BY COUNTRY,
2014 and 2020 (USD MN) 99
FIGURE 54 MIDDLE EAST and AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE,
2015 and 2020 (USD MN) 100
FIGURE 55 EGYPT HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 101
FIGURE 56 SAUDI ARABIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 103
FIGURE 57 UAE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 104
FIGURE 58 ISRAEL HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 106
FIGURE 59 OMAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 107
FIGURE 60 KUWAIT HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 109
FIGURE 61 ZIMBABWE HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 110
FIGURE 62 KENYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 112
FIGURE 63 JORDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 113
FIGURE 64 ALGERIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 115
FIGURE 65 MOROCCO HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 116
FIGURE 66 LIBYA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 118
FIGURE 67 TUNISIA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 119
FIGURE 68 SUDAN HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 121
FIGURE 69 SOUTH AFRICA HEMOSTATS MARKET, BY PRODUCT TYPE, 2015 and 2020 (USD MN) 122
FIGURE 70 MAURITIUS HEMOSTATS MARKET, BY PRODUCT TYPE, 2013-2020 (USD MN) 124
FIGURE 71 U.S. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 126
FIGURE 72 CANADA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 126
FIGURE 73 BRAZIL HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 127
FIGURE 74 GERMANY HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 128
FIGURE 75 FRANCE HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 128
FIGURE 76 U.K. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 129
FIGURE 77 CHINA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 130
FIGURE 78 INDIA HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 130
FIGURE 79 JAPAN HEMOSTATS MARKET: COMPANY SHARE ANALYSIS, 2014 (%) 131
FIGURE 80 JOHNSON and JOHNSON SERVICES, INC: REVENUE MIX, 2014 (%) 135
FIGURE 81 JOHNSON and JOHNSON SERVICES, INC.: REVENUE MIX, 2014 (%) 136
FIGURE 82 C. R. BARD, INC.: REVENUE MIX, 2014 (%) 138
FIGURE 83 BAXTER: REVENUE MIX, 2014 (%) 140
FIGURE 84 BAXTER: REVENUE MIX, 2010-2014 (%) 141
FIGURE 85 B. BRAUN MELSUNGEN AG: REVENUE MIX, 2014 (%) 143
FIGURE 86 B. BRAUN MELSUNGEN AG.: REVENUE MIX, 2014 (%) 144
FIGURE 87 PFIZER INC.: -REVENUE MIX, 2014 (%) 146
FIGURE 88 VASCULAR SOLUTIONS, INC.: REVENUE MIX, 2014 (%) 148
FIGURE 89 VASCULAR SOLUTIONS, INC.: REVENUE MIX, 2014 (%) 149
FIGURE 90 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE MIX, 2014 (%) 153

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hemostasis Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Hemostasis Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

This report on the global hemostasis products market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides ...

Global and Chinese Hemostat Industry, 2016 Market Research Report

Global and Chinese Hemostat Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Hemostat Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Hemostat industry with a focus on the Chinese market. ...

Global Hemostats For Wound Closure Market Research Report 2016

Global Hemostats For Wound Closure Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Hemostats For Wound Closure Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Hemostats For Wound Closure industry, focusing ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.